[A05-20A] Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Last updated 30.08.2010

Project no.:
A05-20A

Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Mental and emotional wellbeing

18.08.2009

Antidepressants: benefit of SNRI is proven

Venlafaxine and duloxetine alleviate symptoms better than sham drug

Current document

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.